ArticleOdontology2026
Salivary antimicrobial peptides histatin-5, beta defensins, human neutrophilic peptides, LL-37, and calprotectin in severe dental caries, with a focus on early childhood caries: a systematic review and meta-analysis.
Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This systematic review and meta-analysis was performed to collect evidence on the association between salivary antimicrobial peptides (AMPs) and severe dental caries, with a focus on Early Childhood caries (ECC). Findings regarding AMPs can assess their potential as biomarkers for disease susceptibility and progression. A comprehensive search of PubMed, Scopus, and ClinicalKey was conducted up to 2025. Studies reporting salivary AMP concentrations in caries-affected and caries-free individuals were included. Risk of bias was assessed using ROBINS-I, and certainty of evidence was evaluated with GRADE. Random-effects meta-analyses were performed to calculate standardized mean differences (SMDs) and correlation coefficients. The AMPs evaluated were histatin-5 (HST-5), human β-defensin-1 (hBD-1), β-defensin-2 (hBD-2), β-defensin-3 (hBD-3), human neutrophil peptides 1-3 (HNP1-3), LL-37, and calprotectin. Using PRISMA guidelines, twelve studies were selected. Histatin-5 (HST-5) was depleted consistently in severe caries (SMD - 20.63; p < 0.01) and severe early childhood caries (ECC) compared to milder disease (SMD - 18.19; p < 0.01). Human β-defensin-1 (SMD - 2.87; p = 0.13) and Human β-defensin-3 (SMD - 0.16; p = 0.47) showed inconsistent and/or insignificant associations. Human β-defensin-2 (hBD-2) was significantly higher in children with ECC versus caries-free controls (SMD 1.65; p = 0.01), with moderate-certainty of evidence. Human neutrophil peptides (HNP1-3) were lower in severe ECC compared to mild disease (SMD - 0.63; p = 0.03), although the certainty was not as much as histatins and hBD-2. LL-37 (SMD - 0.60; p = 0.08) and calprotectin (effect size 0.986; p = 0.812) level associations were of low certainty evidence. Heterogeneity was noticed across most analyses (I² frequently > 80%). Our major findings were that salivary histatin-5 depletion and hBD-2 elevation show consistent associations with caries severity, and may serve as potential biomarkers. For other AMPs assessed, there was insufficient evidence. Robust longitudinal studies of AMPs with standard methodologies are needed to further our knowledge and provide evidence-based recommendations for clinical management.
Indexed as
Identifiers
42295538What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.